| Kelli Yacono, DO | |
|
400 Baileys Run Ln, Springfield, PA 19064-2143 | |
| (610) 505-8350 | |
| (610) 675-1755 |
| Full Name | Kelli Yacono |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 19 Years |
| Location | 400 Baileys Run Ln, Springfield, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578721965 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | OS014411 (Pennsylvania) | Secondary |
| 208M00000X | Hospitalist | OS014411 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
BioInvent International AB today announced data from the GLACIER phase IIa study evaluating BI-204 in patients with stable atherosclerotic vascular disease. BioInvent is developing BI-204 in collaboration with Genentech, a member of the Roche Group.
A medical researcher at the University of Alberta is working with scientists from across North America to find out if there are genetic markers for autism. More than 15 scientists will examine DNA samples from children with autism and their infant siblings to see if the siblings are at high risk.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
NFC is a recent technology offering short-range wireless connectivity which enables smart mobile consumer devices to interact quickly and easily when brought close together or touching. Set up is fast and systems can be intuitively easy to use.
› Verified 4 days ago
| Entity Name | Innovative Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922422849 PECOS PAC ID: 2769615798 Enrollment ID: O20140429000141 |
News Archive
BioInvent International AB today announced data from the GLACIER phase IIa study evaluating BI-204 in patients with stable atherosclerotic vascular disease. BioInvent is developing BI-204 in collaboration with Genentech, a member of the Roche Group.
A medical researcher at the University of Alberta is working with scientists from across North America to find out if there are genetic markers for autism. More than 15 scientists will examine DNA samples from children with autism and their infant siblings to see if the siblings are at high risk.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
NFC is a recent technology offering short-range wireless connectivity which enables smart mobile consumer devices to interact quickly and easily when brought close together or touching. Set up is fast and systems can be intuitively easy to use.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Yacono, DO 400 Baileys Run Ln, Springfield, PA 19064-2143 Ph: (610) 505-8350 | Kelli Yacono, DO 400 Baileys Run Ln, Springfield, PA 19064-2143 Ph: (610) 505-8350 |
News Archive
BioInvent International AB today announced data from the GLACIER phase IIa study evaluating BI-204 in patients with stable atherosclerotic vascular disease. BioInvent is developing BI-204 in collaboration with Genentech, a member of the Roche Group.
A medical researcher at the University of Alberta is working with scientists from across North America to find out if there are genetic markers for autism. More than 15 scientists will examine DNA samples from children with autism and their infant siblings to see if the siblings are at high risk.
Some of these variants, known as variants of concern (VoC), have a much higher rate of transmission and increased mortality than the original SARS-CoV-2 strain. Therefore, it is imperative to assess the efficacy of the available vaccines against the circulating SARS-CoV-2 strains. In addition, tracking the continuously evolving genetic variants is also vital to prevent future outbreaks.
NFC is a recent technology offering short-range wireless connectivity which enables smart mobile consumer devices to interact quickly and easily when brought close together or touching. Set up is fast and systems can be intuitively easy to use.
› Verified 4 days ago